<DOC>
	<DOC>NCT00981305</DOC>
	<brief_summary>The purpose of this study is to determine whether lactate-containing vaginal lubricant is effective in the treatment of young breast cancer survivors with sexual dysfunction.</brief_summary>
	<brief_title>Impact of Lactate-Containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer Survivors</brief_title>
	<detailed_description>Study scheme - study arm: apply lactate-containing lubricants at the time of sexual intercourse and before sleep at least 3 times per a week for 8 weeks - control arm: placebo apply Outcome measures - Female Sexual function Index (FSFI-20): at 0 wk and at 8 wk - vaginal maturation index: at 0 wk and 8 wk - vaginal pH: at 0 wk and 8 wk</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>breast cancer survivors over 20 yearsold premenopausal at the time of diagnosis treated with operation and chemotherapy newly developed dyspareunia after cancer treatment recent (&lt; 2 months) start or cessation of hormonal treatment (tamoxifen etc.) depression or other psychological problems active vaginal infection evidence of cancer recurrence previously use of lactatecontaining lubricants other chronic diseases which severely disturb the sexual life</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>dyspareunia</keyword>
	<keyword>breast cancer</keyword>
	<keyword>sexual dysfunction</keyword>
	<keyword>vaginal lubricant</keyword>
</DOC>